These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26315319)

  • 21. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Xpert HIV-1 Qual assay for resolution of HIV-1 infection in samples with negative or indeterminate Geenius HIV-1/2 results.
    Michaeli M; Wax M; Gozlan Y; Rakovsky A; Mendelson E; Mor O
    J Clin Virol; 2016 Mar; 76():1-3. PubMed ID: 26761545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
    Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
    J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine HIV Test Results in 6 US Clinical Laboratories Using the Recommended Laboratory HIV Testing Algorithm With Geenius HIV 1/2 Supplemental Assay.
    Wesolowski LG; Chavez PR; Cárdenas AM; Katayev A; Slev P; Valsamakis A; Wang YF; Yao JD; Dougherty C; Gillim-Ross L; Harmon C; Delaney KP
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S13-S17. PubMed ID: 32343517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminatory capacity between HIV-1 and HIV-2 of the new rapid confirmation assay Geenius.
    Herssens N; Beelaert G; Fransen K
    J Virol Methods; 2014 Nov; 208():11-5. PubMed ID: 25075934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay.
    Kfutwah A; Lemée V; Ngono HV; De Oliveira F; Njouom R; Plantier JC
    J Clin Virol; 2013 Dec; 58 Suppl 1():e70-5. PubMed ID: 24342480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
    Dubravac T; Gahan TF; Pentella MA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Strip immunoblot assay (SIA) with recombinant antigens and synthetic peptide for detection of anti HIV-1 and HIV-2 antibodies].
    Deguchi M; Yamashita N; Kagita M; Asari S; Yanagihara T
    Kansenshogaku Zasshi; 2001 May; 75(5):371-81. PubMed ID: 11424486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody.
    Saville RD; Constantine NT; Cleghorn FR; Jack N; Bartholomew C; Edwards J; Gomez P; Blattner WA
    J Clin Microbiol; 2001 Jul; 39(7):2518-24. PubMed ID: 11427563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Bio-Rad Geenius HIV 1/2 Confirmation Assay as an Alternative to Western Blot in the Korean Population: A Multi-Center Study.
    Moon HW; Huh HJ; Oh GY; Lee SG; Lee A; Yun YM; Hur M
    PLoS One; 2015; 10(9):e0139169. PubMed ID: 26422281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation in a clinical setting of the performances of a new rapid confirmatory assay for HIV1/2 serodiagnosis.
    Abbate I; Pergola C; Pisciotta M; Sciamanna R; Sias C; Orchi N; Libertone R; Ippolito G; Capobianchi MR
    J Clin Virol; 2014 Sep; 61(1):166-9. PubMed ID: 25037532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
    Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
    J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic evaluation of a new combined HIV p24 antigen and anti-HIV1/2/O screening assay.
    Polywka S; Feldner J; Duttmann H; Laufs R
    Clin Lab; 2001; 47(7-8):351-6. PubMed ID: 11499796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast.
    Masciotra S; Luo W; Youngpairoj AS; Kennedy MS; Wells S; Ambrose K; Sprinkle P; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e54-8. PubMed ID: 23911678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance evaluation of the Bio-Rad Geenius HIV 1/2 supplemental assay.
    Luo W; Sullivan V; Smith T; Peters PJ; Gay C; Westheimer E; Cohen SE; Owen SM; Masciotra S
    J Clin Virol; 2019 Feb; 111():24-28. PubMed ID: 30594702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1/2 screening in blood centers: implementing a two-step serological screening assay approach to reduce donor deferral.
    Stoyanov E; Gozlan Y; Wax M; Levin E; Shvartz L; Shinar E; Mendelson E; Mor O
    Transfusion; 2019 Jun; 59(6):2054-2060. PubMed ID: 30893485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 4th-Generation HIV Antigen/Antibody Combination Assay With 3rd-Generation HIV Antibody Assays for the Occurrence of False-Positive and False-Negative Results.
    Muthukumar A; Alatoom A; Burns S; Ashmore J; Kim A; Emerson B; Bannister E; Ansari MQ
    Lab Med; 2015; 46(2):84-9; quiz e28-9. PubMed ID: 25918186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BioRad BioPlex® HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm.
    Parker J; Carrasco AF; Chen J
    J Clin Virol; 2019 Jul; 116():1-3. PubMed ID: 30981082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.